Q: Q: Can you please shed some light on why the BIG drop in ABBV the last couple of days? Time to worry ?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
-
Profound Medical Corp. (PRN $6.58)
-
WELL Health Technologies Corp. (WELL $4.92)
-
Neighbourly Pharmacy Inc. (NBLY $18.60)
Q: I’m considering an investment in Canadian Health Care. Is it best to buy an ETF an if so which Canadian Health Care ETF do you suggest? If you believe certain health care companies have a better upside potential than a a composite ETF which companies do you suggest?
-
Stryker Corporation (SYK $394.22)
-
iShares Global Healthcare Index ETF (CAD-Hedged) (XHC $64.45)
-
SPDR Biotech ETF (XBI $90.92)
-
WELL Health Technologies Corp. (WELL $4.92)
-
Andlauer Healthcare Group Inc. Subordinate Voting Shares (AND $53.18)
Q: Two part question, deduct as many points as you like.
I'm just wondering if anyone at 5I has glanced at the 195 page(!!) short report that Spruce Point put out last week on Stryker. Anything in particular to be concerned about? I own it in my RRSP, and have been slowly adding to my position. It is the only stock that I own in the health care sector.
Also, what would be your top pick, CA or US in this sector, if I wanted to diversify my portfolio?
Thank you for all that you do.
I'm just wondering if anyone at 5I has glanced at the 195 page(!!) short report that Spruce Point put out last week on Stryker. Anything in particular to be concerned about? I own it in my RRSP, and have been slowly adding to my position. It is the only stock that I own in the health care sector.
Also, what would be your top pick, CA or US in this sector, if I wanted to diversify my portfolio?
Thank you for all that you do.
-
Intuitive Surgical Inc. (ISRG $476.16)
-
AbbVie Inc. (ABBV $210.60)
-
Elevance Health Inc Com (ANTM)
-
Bristol-Myers Squibb Company (BMY $47.92)
-
Edwards Lifesciences Corporation (EW $81.83)
-
WELL Health Technologies Corp. (WELL $4.92)
Q: Hello Team 5i,
I recently sold GUD, my only CDN. or US. Health Care holding. Could you recommend one or more replacements for me? Not sure what your current suggested health Care portfolio weighting should be but that might figure into your response.
I read something recently that indicated that the S&P/TSX Health Care index is down 58% between March 2021 and 2022, might that be correct? If so, would you say this would be a good time to be buying?
Thanks for your wisdom
I recently sold GUD, my only CDN. or US. Health Care holding. Could you recommend one or more replacements for me? Not sure what your current suggested health Care portfolio weighting should be but that might figure into your response.
I read something recently that indicated that the S&P/TSX Health Care index is down 58% between March 2021 and 2022, might that be correct? If so, would you say this would be a good time to be buying?
Thanks for your wisdom
Q: What would be your number one pick in the health field.
Q: I have done very well with ABBV. Thank you. Is it time to reduce or sell outright now, please?
Q: Do you see any upside in keeping AstraZeneca for a year, or is best to cash out now, after having made some profit
Q: Which would you choose if only one were to be added to a portfolio? I have owned SYK and know it to be a relatively steady-eddy company but one that has had some solid growth over the years. ISRG showed very promising stock appreciation but that has certainly cooled off over the past several months. Which do you feel has the better total upside over the next 5 years?
Appreciate your insight.
Paul F.
Appreciate your insight.
Paul F.
Q: Hello,
Can I have your thoughts on the 1-3 year potential this stock? Thank you.
Can I have your thoughts on the 1-3 year potential this stock? Thank you.
-
Exact Sciences Corporation (EXAS $47.47)
-
Invitae Corporation (NVTA)
-
CRISPR Therapeutics AG (CRSP $54.32)
-
Guardant Health Inc. (GH $61.40)
-
Twist Bioscience Corporation (TWST $28.59)
-
Intellia Therapeutics Inc. (NTLA $10.52)
-
10x Genomics Inc. (TXG $14.30)
-
DermTech Inc (DMTK)
Q: Looking at companies in these companies, some have more current business (EXAS) while others are based more on potential. Can you please rank each in order based on these two approaches:
1. Most growth potential
2. Best overall investment
Please comment briefly on why you would place a particular company as "Best in class" for approach 1 and 2.
1. Most growth potential
2. Best overall investment
Please comment briefly on why you would place a particular company as "Best in class" for approach 1 and 2.
Q: The following was in the Globe today and I quote: "Canaccord Genuity’s Doug Taylor lowered his Well Health Technologies Corp. to $10 from $12 with a “buy” rating, while PI Financial’s Kris Thompson cut his target to $9 from $10.50 with a “buy” rating. The AVERAGE is $10.12."
And yet is sits at $5.10. After a good, solid quarter. I just shake my head and wonder what I am missing?
If it wasn't for 5i I would have all my money in a sock hidden under the mattress.
And yet is sits at $5.10. After a good, solid quarter. I just shake my head and wonder what I am missing?
If it wasn't for 5i I would have all my money in a sock hidden under the mattress.
Q: Pfizer looks attractive from a valuation and dividend perspective, but what is your opinion of their pipeline? Anything coming off patent or any promising drugs coming that would affect the top line? Thanks!
Q: My original 5% position @ $8.18 p/p is now reduced to 3%.Your initial recommendation is $2.83 with current rating of B+.The famous billionarie,Mr Kai Sing Li is part owner. Despite so many acquistions the stock has steadily declined from a 1yr H of $8.86 in July,2021 to recent low of $3.76 in mid Jan & appears to have found a base of some $4.Good Q on Mar 31 resulted in rise of.29(after high of + .56)& dropped 0.20 to $5.01 the next trading day.Very disappointed with the performance..Your thoughts. Txs for u usual great services & views
Q: When I briefly heard a portion of Peter's webinar segment of when to sell. If you listen to it again how do you apply that to GUD?
It would seem from a cursory listen to be/have been a sell.
Sheldon
It would seem from a cursory listen to be/have been a sell.
Sheldon
Q: Good morning,
I understand that Valens announced a deal yesterday where "underwriters have agreed to purchase, on a bought deal basis, 10,613,207 units of the company at a price of $2.65 per unit." The stock plunged 25% yesterday on the news to $2.16. I am sad to admit that I am ignorant to why this stock dropped so much on the news - any insights you can provide? Also, I bought this stock with a 5-10 year hold plan - still a good long-term company?
I understand that Valens announced a deal yesterday where "underwriters have agreed to purchase, on a bought deal basis, 10,613,207 units of the company at a price of $2.65 per unit." The stock plunged 25% yesterday on the news to $2.16. I am sad to admit that I am ignorant to why this stock dropped so much on the news - any insights you can provide? Also, I bought this stock with a 5-10 year hold plan - still a good long-term company?
Q: Could you comment on WELL's quarterly results as well as your general outlook of the stock? Thanks in advance. - Jeff
-
AbbVie Inc. (ABBV $210.60)
-
Johnson & Johnson (JNJ $179.29)
-
Pfizer Inc. (PFE $25.88)
-
Stryker Corporation (SYK $394.22)
-
Veeva Systems Inc. Class A (VEEV $290.86)
-
Viatris Inc. (VTRS $10.65)
Q: Hi Peter and Staff
Looking at my health care basket, I have a couple of losers in it VEEV and VTRS.
I have had losers I regretted selling and losers I wish I had not wasted opportunity cost on.......I am fine doing either....Do you think the risk/reward of selling either or both of these to top up ABBV,PFE,SYK or JNJ would be a good move in the long run ignoring how many positions I have or should I hang on. If a sale is suggested which order would you top up the 4 stocks mentioned.
Thanks for all you do
Dennis
Looking at my health care basket, I have a couple of losers in it VEEV and VTRS.
I have had losers I regretted selling and losers I wish I had not wasted opportunity cost on.......I am fine doing either....Do you think the risk/reward of selling either or both of these to top up ABBV,PFE,SYK or JNJ would be a good move in the long run ignoring how many positions I have or should I hang on. If a sale is suggested which order would you top up the 4 stocks mentioned.
Thanks for all you do
Dennis
Q: Hi folks
BMO Investorline's chart for DXCM is completely different than your chart? Can you explain please. Your chart shows huge jump in price on about March 25th. Is this correct? Is there still room for gain? Would you BUY now? My Health sector weight is 4.55% which is down from its high due to the market of course. (ZTS, PFE, GH, VEEV, BNTX)
Much thanks for keeping me well on track through the ups and downs for about 8 years now..I recommend you often.
BMO Investorline's chart for DXCM is completely different than your chart? Can you explain please. Your chart shows huge jump in price on about March 25th. Is this correct? Is there still room for gain? Would you BUY now? My Health sector weight is 4.55% which is down from its high due to the market of course. (ZTS, PFE, GH, VEEV, BNTX)
Much thanks for keeping me well on track through the ups and downs for about 8 years now..I recommend you often.
Q: What is your current view on Bausch Health Companies? It looks like a good price now. Or, would you prefer any of other names in health care now such as PFE, LLY or JNJ? Already hold ABBV and MRK.
Q: TH TMX
Any Hope for this company. / Should I move on /Your comment on last quarter please. Thanks RAK.
Any Hope for this company. / Should I move on /Your comment on last quarter please. Thanks RAK.